Dr. Reddy's Laboratories has launched amlodipine besylate and atorvastatin calcium tablets in the U.S. market.


Dr. Reddy's Laboratories, amlodipine besylate and atorvastatin calcium tablets, Caduet generic, Pfizer, Norvasc, Lipitor, heart disease, high blood pressure, chest pain, angina






































































































































































































































INSIDE THIS ISSUE
News
Opinion
Other Services
Reprints / E-Prints
Submit News
White Papers

Supplier News Breaks Archives

Dr. Reddy's releases Caduet generic

March 27th, 2014

HYDERABAD, India – Dr. Reddy's Laboratories has launched amlodipine besylate and atorvastatin calcium tablets in the U.S. market.

The company said Thursday that its amlodipine besylate and atorvastatin calcium product comes in 30- and 90-count bottles and in dosages of 2.5/10 mg, 2.5/20 mg, 2.5/40 mg, 5/10 mg, 5/20 mg, 5/40 mg, 5/80 mg, 10/10 mg, 10/20 mg, 10/40 mg and 10/80 mg.

According to Dr. Reddy's, the product is a therapeutic equivalent generic version of Pfizer Inc.'s Caduet tablets. Dr. Reddy's launched its Caduet generic in the United States on March 26 following the product's approval by the Food and Drug Administration.

Caduet tablets combines two medicines — Norvasc (amlodipine besylate) and Lipitor (atorvastatin calcium) — and is used to treat high blood pressure, chest pain (angina) and to lower the risk of stroke, heart attack and other heart complications in people with type 2 diabetes, coronary heart disease or other risk factors.

Branded and generic Caduet tablets had U.S. sales of approximately $163 million (MAT) for the 12 months ended in January 2014, according to IMS Health figures reported by Dr. Reddy's.

Advertisement